Adaptation of a Transdiagnostic Behavioral Activation Telehealth Group for Autistic Adults
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Autism Spectrum Disorder
- Sponsor
- Rutgers, The State University of New Jersey
- Enrollment
- 6
- Locations
- 1
- Primary Endpoint
- Change in Clinician Global Impairment rating
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the feasibility, acceptability and effectiveness of a telehealth Group Behavioral Activation Therapy (GBAT) for autistic adults.
Detailed Description
Detailed Description: This study is being done to demonstrate the feasibility, acceptability and effectiveness of a telehealth Group Behavioral Activation Therapy (GBAT) for autistic adults. GBAT is intended to help adults manage stress, anxiety, down moods, and anger. Similar programs have been shown to be effective in other contexts but has not yet been used for autistic adults or delivered via telehealth. Because this is a new intervention, the investigators are interested in learning 1) whether GBAT can be done with autistic adults (feasibility), 2) what autistic adults think about GBAT (acceptability), and 3) whether GBAT is effective for helping autistic adults cope with their feelings. Results from this study will be used to inform adaptation to the intervention and planning for future studies to further explore its effectiveness. For this initial feasibility study, 8 autistic adults (18-40 years old) with VIQ and NVIQ\>85, reading composite at least 6th grade level and elevated symptoms of depression, anxiety or anger will be recruited.
Investigators
Vanessa H. Bal, PhD
Karmazin & Lillard Chair in Adult Autism; Associate Professor
Rutgers, The State University of New Jersey
Eligibility Criteria
Inclusion Criteria
- •Be 18-40 years old
- •Have a confirmed diagnosis of Autism Spectrum Disorders (ASD).
- •Have access to a device (e.g., computer with a webcam or smartphone) in order to complete online surveys and participate in the telehealth videoconferencing sessions
- •\*Have a VIQ and NVIQ of 85 or above
- •\*Have at least a 6th grade reading composite
- •\*Have elevated symptoms of depression, anxiety or anger. This will be determined based on scoring above the borderline or mild threshold on at least one of 3 screening measures (MINI; ASR; DASS-21).
Exclusion Criteria
- •Are younger than 18 years old, or older than 40 years old (Children are excluded because the focus is on adapting GBAT for adults; Individuals above 40 are excluded to restrict the adult focus to young adults that are more likely to be in similar life stages).
- •Do not have an ASD diagnosis (because the study as the purpose of the current research is to examine GBAT's feasibility with autistic adults).
- •Both VIQ and NVIQ below 85 OR less than 6th grade reading level
- •Do not have elevated scores of depression, anxiety, or anger on the symptom screening measures.
- •Are unable to understand English fluently (because the instruments being investigated are currently only validated in English and the intervention will be delivered in English).
- •Are currently enrolled in another behavioral therapy or psychotherapy targeting depression,
- •the PI's clinical judgment that it would not be in the adult's best interest to be enrolled (e.g., due to factors that may affect their engagement or comfort in the group).
Outcomes
Primary Outcomes
Change in Clinician Global Impairment rating
Time Frame: 10 week study period;
The CGI is a 7 point scale on which the clinician rates the severity of the client's impairment. The scale ranges from 1 (Normal, not at all ill) to 7 Extremely Ill; higher scores indicate more impairment.
Change in symptoms on the Adult Self Report (ASR)
Time Frame: 10 week study period; 4 week post-treatment
The ASR is a an assessment of adult psychopathology (e.g., anxiety, depression symptoms). Most of the items are on a 3 point scale including: (0) Not true, (1) Somewhat or sometimes true, and (2) Very often or often true.
Secondary Outcomes
- Change in Behavioral Activation for Depression Scale(10 week study period; 4 week post-treatment)
- Change in Adaptive Behavior Assessment System - 3 (ABAS-3)(10 week study period)
- Change in symptoms on the Depression Anxiety Stress Scales-21(10 week study period; 4 week post-treatment)
- Change in distress on Patient Health Questionnaire (PHQ-9)(10 week study period)
- Change in anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)(10 week study period)
- Change in Idiographic target goals(10 week study period; 4 week post-treatment)